Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Sorafenib in combination with paclitaxel for locally recurrent or metastatic bre...
Prof William Gradishar - Robert H. Lurie Comprehensive Cancer Center, USA
Sorafenib in combination with paclitaxel for locally recurrent or metastatic breast cancer ( Prof William Gradishar - Robert H. Lurie Comprehensive Cancer Center, USA )
28 Jan 2010
A novel strategy in treating endocrine resistance using combination therapy
Dr Rajeshwar Rao Tekmal - University of Texas Health Science Center, San Antonio...
A novel strategy in treating endocrine resistance using combination therapy ( Dr Rajeshwar Rao Tekmal - University of Texas Health Science Center, San Antonio, USA )
28 Jan 2010
Lapatinib alone or in combination with trastuzumab for HER2+ metastatic breast c...
Dr Kimberly Blackwell - Duke University Medical Center, USA
Lapatinib alone or in combination with trastuzumab for HER2+ metastatic breast cancer ( Dr Kimberly Blackwell - Duke University Medical Center, USA )
28 Jan 2010
Bevacizumab in combination with chemotherapy for second-line treatment of HER2-n...
Prof Adam Brufsky - University of Pittsburgh Cancer Institute, USA
Bevacizumab in combination with chemotherapy for second-line treatment of HER2-negative metastatic breast cancer ( Prof Adam Brufsky - University of Pittsburgh Cancer Institute, USA )
28 Jan 2010
Bevacizumab plus docetaxel compared with placebo plus docetaxel for locally recu...
Dr David Miles - Mount Vernon Hospital, United Kingdom
Bevacizumab plus docetaxel compared with placebo plus docetaxel for locally recurrent or metastatic breast cancer ( Dr David Miles - Mount Vernon Hospital, United Kingdom )
28 Jan 2010
Exemestane vs tamoxifen followed by exemestane
Dr Daniel Rea - University of Birmingham, UK
Exemestane vs tamoxifen followed by exemestane ( Dr Daniel Rea - University of Birmingham, UK )
28 Jan 2010
Adult acute lymphoblastic leukaemia
Prof Anthony Goldstone - Director, North London Cancer Network
Adult acute lymphoblastic leukaemia ( Prof Anthony Goldstone - Director, North London Cancer Network )
27 Jan 2010
Using biology of tumours to predict effective therapies
Dr Laura Van`t Veer - The Netherlands Cancer Institute, Amsterdam, The Netherlan...
Using biology of tumours to predict effective therapies ( Dr Laura Van`t Veer - The Netherlands Cancer Institute, Amsterdam, The Netherlands )
27 Jan 2010
Translation of endocrine systemic treatment
Prof Giuseppe Viale - European Institute of Oncology, Milan, Italy
Translation of endocrine systemic treatment ( Prof Giuseppe Viale - European Institute of Oncology, Milan, Italy )
27 Jan 2010
T-cell therapies
Dr Catherine Bollard - Baylor College of Medicine, Texas, USA
T-cell therapies ( Dr Catherine Bollard - Baylor College of Medicine, Texas, USA )
27 Jan 2010
The International Consortium on Acute Promyelocytic Leukemia
Dr Eduardo Rego - University of Sao Paulo, Brazil
The International Consortium on Acute Promyelocytic Leukemia ( Dr Eduardo Rego - University of Sao Paulo, Brazil )
27 Jan 2010
Myeloid supressor cells
Prof John Harlan - University of Washington, USA
Myeloid supressor cells ( Prof John Harlan - University of Washington, USA )
27 Jan 2010